LINDSAY LEWIS: Open Payments
NPI 1225416258 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$202 in 9 payments from 7 companies in 2025. Trend: 2023 $372 · 2024 $261 · 2025 $202
Food & beverage: $202
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $50 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| PFIZER INC. | 1 | $23 |
| Boston Scientific Corporation | 1 | $20 |
| Caris MPI, Inc. | 1 | $19 |
| Myriad Genetic Laboratories, Inc. | 1 | $15 |
Products named: LYNPARZA, JEMPERLI, TIVDAK, Varithena Administration Pack, MI CANCER SEEK, MYRISK.
Industry payments across GA — which companies pay providers there.
